KNtp-SUR1 core fusion
(Plasmid
#216212)
-
Purposefor expression of KNtp-SUR1 fusion protein in BacMam system
-
Depositing Lab
-
Sequence Information
Ordering
This material is available to academics and nonprofits only.
| Item | Catalog # | Description | Quantity | Price (USD) | |
|---|---|---|---|---|---|
| Plasmid | 216212 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 | |
Backbone
-
Vector backbonepBM
-
Vector typeMammalian Expression
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameSUR1 core
-
SpeciesCricetus cricetus
-
Mutationdeletion of TMD0
-
GenBank IDL40623.1
-
Tag
/ Fusion Protein
- GFP-MBP (N terminal on insert)
Resource Information
-
Supplemental Documents
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
How to cite this plasmid
( Back to top)
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
KNtp-SUR1 core fusion was a gift from Lei Chen (Addgene plasmid # 216212 ; http://n2t.net/addgene:216212 ; RRID:Addgene_216212) -
For your References section:
Structural Insights Into the High Selectivity of the Anti-Diabetic Drug Mitiglinide. Wang M, Wu JX, Chen L. Front Pharmacol. 2022 Jun 30;13:929684. doi: 10.3389/fphar.2022.929684. eCollection 2022. 10.3389/fphar.2022.929684 PubMed 35847046
